KALOCYTE
Kalocyte is a pre-clinical stage healthcare biotech startup company that provides artificial red blood cell substitutes used for trauma care related services. The company develops a demonstrated proof of concept for ErythroMer, a dried, bio-inspired artificial red blood cell envisioned for use when stored red blood cells are unavailable, undesirable, or in short supply. Kalocyte was founded in 2016 and is headquartered in Baltimore, Maryland.
KALOCYTE
Industry:
Biotechnology Emergency Medicine Health Care
Founded:
2016-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.kalocyte.com
Total Employee:
1+
Status:
Active
Total Funding:
1.47 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Apache
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Current Employees Featured
Allan Doctor Chief Scientific Officer and Founding Partner @ Kalocyte
Chief Scientific Officer and Founding Partner
2016-01-01
Phil Spinella Co-Founder @ Kalocyte
Co-Founder
Elaine Haynes President and CEO @ Kalocyte
President and CEO
2018-08-01
Dipanjan Pan Co-Founder and Chief Technology Officer @ Kalocyte
Co-Founder and Chief Technology Officer
2016-01-01
Founder
Investors List
New York Blood Center
New York Blood Center investment in Seed Round - Kalocyte
(Momentum Fund) University System of Maryland
(Momentum Fund) University System of Maryland investment in Seed Round - Kalocyte
Small Business Innovation Research
Small Business Innovation Research investment in Grant - Kalocyte
BioGenerator
BioGenerator investment in Seed Round - Kalocyte
St. Louis Arch Angels
St. Louis Arch Angels investment in Seed Round - Kalocyte
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship
Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship investment in Grant - Kalocyte
Official Site Inspections
http://www.kalocyte.com
- Host name: box2046.bluehost.com
- IP address: 67.222.38.82
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
More informations about "Kalocyte"
KaloCyte | ErythroMer - a red blood cell substitute
There is a Critical Need. Blood loss is the leading cause of preventable death after trauma. However, stored blood products are at times unavailable (pre-hospital care, austere …See details»
Kalocyte - Crunchbase Company Profile & Funding
Kalocyte is a pre-clinical stage healthcare biotech startup company that provides artificial red blood cell substitutes used for trauma care related services. The company develops a …See details»
OUR TEAM - KaloCyte
KaloCyte - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 26, 2025 KaloCyte is a seed company based in St. Louis (United States), founded in 2016 by Allan Doctor, Philip Spinella and Dipanjan Pan. It operates as a Developer of a …See details»
KaloCyte 2025 Company Profile: Valuation, Funding & Investors
KaloCyte General Information Description. Developer of red blood cell substitutes designed for trauma care-related services. The company's cell substitutes are designed for context …See details»
KaloCyte, Inc. - LinkedIn
KaloCyte offices and labs are sited within the UM School of Medicine’s Center for Blood Oxygen Transport and Hemostasis (CBOTH) directed by Allan Doctor, MD (KaloCyte Co-Founder and CSO). Skip ...See details»
Kalocyte - Funding, Financials, Valuation & Investors - Crunchbase
Kalocyte provides red blood cell substitutes used for trauma care related services. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
KaloCyte Company Profile - Office Locations, Competitors ... - Craft
KaloCyte is a healthcare biotech company that develops artificial red blood cell substitutes. It develops ErythroMer, bio-inspired nanoparticle-encapsulated human hemoglobin that can be …See details»
Kalocyte Inc - VentureRadar
KaloCyte is pioneering the development of ErythroMer™, a dried, bio-inspired artificial red blood cell designed to treat life-threatening blood loss when stored red blood cells are unavailable, …See details»
KaloCyte, Inc. (KaloCyte, Inc.) - 药物管线_专利_临床试验_投融营收
了解KaloCyte, Inc. (KaloCyte, Inc.)公司的药物管线，治疗领域，技术平台，以及它的6篇新闻。 ... (NYBC) is a nonprofit organization that is one of the largest independent, community-based …See details»
Kalocyte | Seed - National Institutes of Health
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https ... KaloCyte was founded by a …See details»
C-Suite Insights with Elaine Haynes, CEO of KaloCyte
Mar 4, 2024 Please tell us a little bit about yourself and your organization. I am CEO of KaloCyte, Inc., a pre-clinical biotech startup developing an artificial red blood cell substitute …See details»
Kalocyte - Contacts, Employees, Board Members, Advisors & Alumni
Kalocyte provides red blood cell substitutes used for trauma care related services. New. Resources. Advanced Search. Start Free Trial ... Experience the new Crunchbase, powered …See details»
KaloCyte Closes Investment from New York Blood Center
Jul 20, 2022 KaloCyte’s mission is to make an easy-to-use, shelf-stable red blood substitute available anywhere and at any time. ... (NYBC) is a nonprofit organization that is one of the …See details»
Scorpius Holdings Announces Collaboration with KaloCyte to
Jan 22, 2025 KaloCyte is a pre-clinical biotech therapeutic startup company developing ErythroMer™, a bioengineered artificial red blood cell (RBC) substitute that can be freeze …See details»
Scorpius Holdings Announces Collaboration with KaloCyte to …
DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing …See details»
NEWS - KaloCyte
KaloCyte, Inc., a pre-clinical biotech startup company developing a bio-inspired red blood cell substitute called ErythroMer™, announced today that it has been selected to join Blue Knight, …See details»
KaloCyte - UM BioPark
KaloCyte has demonstrated proof of concept for ErythroMer, a dried, bio-inspired artificial red blood cell envisioned for use when stored red blood cells are unavailable, undesirable or in …See details»
SickScience Is Biohacking Beauty With Vegan Exosomes - Forbes
4 hours ago Biotech beauty brand SickScience is pushing the industry forward with cutting-edge technology that is clinically proven to quickly deliver results.See details»
Press Release: KaloCyte CEO to Present at NIH Innovation …
Nov 4, 2019 KaloCyte CEO to Present at NIH Innovation Conference and Life Sciences Summit Company Continues Momentum Following Recent Relocation to Baltimore . BALTIMORE, …See details»